3Wolf G ,Zivadeh FN. Molecular mechanism of diabetic renal hypetrophy[J]. Kidney Int,1999,56:393.
4Gillbert RE,Cooper ME.The tubulointerstitium in progressive diabetic kidney disease:More than an aftermath of glomerular injury[J].Kidney Int,1999,56:1627.?A
5Solerte SB,Severgnini S,Locatelli M,et al .Nephelometry in the clinical assessment of glomerular proteinuria and tubular function in diabetic nephropathy[J].Clin Nephrol,1997,48(3):151.
6Fine LG,Ong ACM,Norman JT,et al.Mechanisms of tubulointerstitial injury in progressive renal diseases[J].Eur J Clin Invest,1993,23:259.
7Hong CY, Chia KS, Ling SL. Urinary protein excretion in type 2 diabetes with complications. J Diabetes complications, 2000,14(5):259- 65.
8Salem MA,El- Habashy SA,Saeid OM,et al. Urinary excretion of Nacetyl - beta - D- glucosaminidase and retinol binding protein as alternative indicators of nephropathy in patients with type 1 diabetes mellitus.Pediatr Diabetes,2002,3(1) :37 -41.
9Torffvit O,Agardh CD,Thulin T.a study of Tamm- Horsfall protein excretion in hypertention patients and type 1 diabetic patients. J Scand J Urol Nephrol, 1999,33(3): 187 - 191.
10Wada T, Sakai N. Up - regulation of monocyte chemoattractant protein in tubulointerstitial lesion of human diabetic nephropathy. Kidney int,2000,58:1492 - 1499.
7Schwart AV,Hillier TA,Sellmeyer DE,et al.Older women with diabetes have a higher risk of falls:a prospective study.Dibetes Care,2002,25(10):1749-1754.
8Okuno S,Inaba M,Kitatani K,et al.Serum levels of C-terminal telopeptide of type Ⅰ collagen:a useful new marker of cortical bone loss in hemodialysis patients.Osteoporos Int,2005,16 (5):501-509.
9Botushanov NP,Orbetzova MM.Bone mineral density and fracture risk in patients with type 1 and type 2 diabetes mellitus.Folia Med (Plovdiv),2009,51 (4):12-17.
10Iwasaki Y,Yamato H,Nii-Kono T,et al.Uremic toxin and bone metabolism.J Bone Miner Metab,2006,24(2):172-175.
